ArticleJournal of hepatocellular carcinoma2023

Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre.

Guangxin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.